NASDAQ
Actavia Life Sciences, Inc. (RASP) has a free cash flow growth of 24.32% as of Friday, May 29, 2026. This represents a 104.21% increase compared to its 12-month average of -577.32%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.